Clinical Trials · NCT06214741
A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Boehringer Ingelheim
- Enrollment
- 307
- Start date
- Feb 2024
- Locations
- 28 sites, China
- Primary endpoint
- Percentage change in body weight from baseline to Week 52